| 33.87 Data as of 3:52pm ET |  -0.41 / -1.20%Today’s Change | 25.01 Today|||52-Week Range 38.32 | +29.13% Year-to-Date |
| Merck Enters into Strategic Deal - Analyst Blog May 22 / Zacks.com | Setback for Endo Health on Opana ER - Analyst Blog May 13 / Zacks.com |
| Previous close | 34.28 |
| Today’s open | 33.96 |
| Day’s range | 33.51 - 34.11 |
| Volume | 612,120 |
| Average volume (3 months) | 2,613,328 |
| Market cap | $3.8B |
| Dividend yield | -- |
| Earnings growth (last year) | -512.90% |
| Earnings growth (this year) | -15.26% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +10.89% |
| P/E ratio | NM |
| Price/Sales | 1.00 |
| Price/Book | 3.54 |
| Today’s change | Today’s % change | |
|---|---|---|
| MDVNMedivation Inc | -1.00 | -2.01% |
| JAZZJazz Pharmaceuticals... | +0.71 | +1.13% |
| SLXPSalix Pharmaceutical... | +0.66 | +1.11% |
| THRXTheravance Inc | -0.51 | -1.37% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $1.16 |
| Annual revenue (last year) | $3.0B |
| Annual profit (last year) | -$740.3M |
| Net profit margin | -24.45% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Rajiv de Silva, MBA |
Chief Operating Officer Julie H. McHugh, MBA |
Corporate headquarters Malvern, Pennsylvania |
.
